Condition: Glioblastoma Multiforme · Glycolytic Index · Epidermal Growth Factor Receptor · Sponsor: Jonsson Comprehensive Cancer Center
The purpose of this project is to validate a new combined MRI and PET imaging technique as a biomarker or measure of glycolysis in brain tumors. To accomplish this, the investigators propose obtaining image-guided measures of tissue pH and biopsied tissue in tumor areas selected for bulk resection surgery. Investigators will then correlate the imaging measurements with pH, RNA expression, protein expression, and bioenergetics measurements of key glycolytic enzymes.
This description comes directly from the study's public registry record.
Raksha Nagaraj · 310-794-8995 · RNagaraj@mednet.ucla.edu
Saima Chaabane · 310-794-8995 · schaabane@mednet.ucla.edu
Always discuss trial participation with your own doctor first.
| University of California at Los Angeles | Los Angeles, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06059690